Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,059,004 papers from all fields of science
Search
Sign In
Create Free Account
MK 0791
Known as:
MK791
, MK 791
, MK-791
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
Cilastatin
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
1984
1984
Treatment of staphylococcal pyelonephritis in rats with N-formimidoyl thienamycin.
P. Guze
,
G. Kalmanson
,
K. Ishida
,
L. R. Freedman
,
L. B. Guze
Chemioterapia : international journal of the…
1984
Corpus ID: 11262079
The therapeutic efficacy of N-formimidoyl thienamycin alone or coadministered with MK0791, an inhibitor of renal dehydropeptidase…
Expand
1983
1983
Ocular penetration of N-formimidoyl thienamycin (MK-787) and potentiation by dipeptidase inhibitor (MK-791).
K. Finlay
,
C. Carlson
,
A. Chow
Investigative Ophthalmology and Visual Science
1983
Corpus ID: 19187404
N-formimidoyl thienamycin (MK-787) is a new beta-lactam with potent activity against both aerobic and anaerobic gram-positive and…
Expand
1983
1983
Intrathecal penetration of N-formimidoyl thienamycin in normal rabbits: potentiation by coadministration of renal dipeptidase enzyme inhibitor
A. Chow
,
K. Finlay
,
H. Stiver
,
C. Carlson
Antimicrobial Agents and Chemotherapy
1983
Corpus ID: 32481444
The intrathecal penetration of N-formimidoyl thienamycin (MK0787) with or without coadministration of the renal dipeptidase…
Expand
1983
1983
A randomized study comparing clinical efficacy and safety of thienamycin formamidine (MK0787)/renal dipeptidase inhibitor (MK0791) and cefazolin.
B. Ribner
,
R. Raeder
,
M. Hollstein
,
E. Freimer
Journal of Antimicrobial Chemotherapy
1983
Corpus ID: 10571259
Twenty-one hospitalized patients with infectious diseases were randomly assigned to receive either thienamycin formamidine/renal…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE
or Only Accept Required